Cargando…

TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth

Malignant mesothelioma (MM) is an incurable malignancy that is caused by exposure to asbestos and is accompanied by severe fibrosis. Because MM is usually diagnosed at an advanced stage and clinical identification of early lesions is difficult, its molecular pathogenesis has not been completely eluc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujii, Makiko, Toyoda, Takeshi, Nakanishi, Hayao, Yatabe, Yasushi, Sato, Ayuko, Matsudaira, Yasue, Ito, Hidemi, Murakami, Hideki, Kondo, Yutaka, Kondo, Eisaku, Hida, Toyoaki, Tsujimura, Tohru, Osada, Hirotaka, Sekido, Yoshitaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302232/ https://www.ncbi.nlm.nih.gov/pubmed/22329991 http://dx.doi.org/10.1084/jem.20111653

Ejemplares similares

Convergent signaling in the regulation of connective tissue growth factor in malignant mesothelioma: TGFβ signaling and defects in the Hippo signaling cascade
por: Fujii, Makiko, et al.
Publicado: (2012)

Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations
por: Sato, Tatsuhiro, et al.
Publicado: (2023)

Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma
por: Sekido, Yoshitaka
Publicado: (2018)

Three newly established immortalized mesothelial cell lines exhibit morphological phenotypes corresponding to malignant mesothelioma epithelioid, intermediate, and sarcomatoid types, respectively
por: Sato, Tatsuhiro, et al.
Publicado: (2021)

SMG6 regulates DNA damage and cell survival in Hippo pathway kinase LATS2-inactivated malignant mesothelioma
por: Suzuki, Koya, et al.
Publicado: (2022)

NF2 alteration in mesothelioma
por: Sekido, Yoshitaka, et al.
Publicado: (2023)

Functional differences between wild-type and mutant-type BRCA1-associated protein 1 tumor suppressor against malignant mesothelioma cells
por: Hakiri, Shuhei, et al.
Publicado: (2015)

Incidence and Risk Factors of Chest Wall Metastasis at Biopsy Sites in Patients with Malignant Pleural Mesothelioma
por: Hashimoto, Masaki, et al.
Publicado: (2022)

NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma
por: Sato, Tatsuhiro, et al.
Publicado: (2018)

Development of a New Rapid Isolation Device for Circulating Tumor Cells (CTCs) Using 3D Palladium Filter and Its Application for Genetic Analysis
por: Yusa, Akiko, et al.
Publicado: (2014)

Successful salvage surgery following multimodal therapy in a patient who harboured ALK‐rearranged advanced lung adenocarcinoma with multiple organ metastases
por: Horio, Yoshitsugu, et al.
Publicado: (2019)

Mesothelioma: Hippo pathway as a target, lessons from COMMAND
por: Fennell, Dean A., et al.
Publicado: (2019)

EGCG induces human mesothelioma cell death by inducing reactive oxygen species and autophagy
por: Satoh, Motohiko, et al.
Publicado: (2013)

Predictive clinical parameters for the response of nivolumab in pretreated advanced non-small-cell lung cancer
por: Oya, Yuko, et al.
Publicado: (2017)

Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue
por: Hida, Tomoyuki, et al.
Publicado: (2015)

Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia
por: Li, Zan, et al.
Publicado: (2019)

Oxytocin receptor is a promising therapeutic target of malignant mesothelioma
por: Kodama, Yuta, et al.
Publicado: (2021)

Frequent homozygous deletion of Cdkn2a/2b in tremolite‐induced malignant mesothelioma in rats
por: Okazaki, Yasumasa, et al.
Publicado: (2020)

Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation
por: Lin, Kimberly C., et al.
Publicado: (2017)

Anaplastic lymphoma kinase gene rearrangements in patients with advanced-stage non-small-cell lung cancer: CT characteristics and response to chemotherapy
por: Park, Jangchul, et al.
Publicado: (2014)

Establishment and characterization of NCC-DMM1-C1, a novel patient-derived cell line of desmoplastic malignant pleural mesothelioma
por: Noguchi, Rei, et al.
Publicado: (2022)

Imipramine impedes glioma progression by inhibiting YAP as a Hippo pathway independent manner and synergizes with temozolomide
por: Wang, Yan, et al.
Publicado: (2021)

Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma
por: Park, Jangchul, et al.
Publicado: (2016)

Hyaluronic acid enhances cell migration and invasion via the YAP1/TAZ-RHAMM axis in malignant pleural mesothelioma
por: Shigeeda, Wataru, et al.
Publicado: (2017)

Possible Therapeutic Utility of anti-Cell Adhesion Molecule 1 Antibodies for Malignant Pleural Mesothelioma
por: Hagiyama, Man, et al.
Publicado: (2022)

Heterogeneity of Hippo signalling activity in different histopathologic subtypes of renal cell carcinoma
por: Duong, Nguyen Xuong, et al.
Publicado: (2022)

Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial)
por: Hasegawa, Seiki, et al.
Publicado: (2015)

Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT Study
por: Fujimoto, Nobukazu, et al.
Publicado: (2020)

Characterization of High‐grade Neuroendocrine Tumors of the Lung in Relation to menin Mutations
por: Haruki, Nobuhiro, et al.
Publicado: (2000)

The Hippo pathway uses different machinery to control cell fate and organ size
por: Pojer, Jonathan M., et al.
Publicado: (2021)

CADM1 associates with Hippo pathway core kinases; membranous co–expression of CADM1 and LATS2 in lung tumors predicts good prognosis
por: Ito, Takeshi, et al.
Publicado: (2019)

Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesothelioma
por: Wang, Shenqi, et al.
Publicado: (2016)

Exposure to High Doses of Lipopolysaccharide during Ovalbumin Sensitization Prevents the Development of Allergic Th2 Responses to a Dietary Antigen
por: Torii, Ikuko, et al.
Publicado: (2014)

Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma
por: Li, Qi, et al.
Publicado: (2015)

Nivolumab for the treatment of Japanese patients with advanced metastatic non-small cell lung cancer: a review of clinical trial evidence for efficacy and safety
por: Hida, Toyoaki
Publicado: (2018)

Anaplastic lymphoma kinase inhibitor development: enhanced delivery to the central nervous system
por: Hida, Toyoaki
Publicado: (2023)

Coronary artery spasm — Clinical features, pathogenesis and treatment —
por: YASUE, Hirofumi, et al.
Publicado: (2019)

Preventive effects of low‐intensity endurance exercise for severe hyperglycemia‐induced capillary regression in non‐obese type 2 diabetes rat skeletal muscle
por: Morifuji, Takeshi, et al.
Publicado: (2021)

Higher frequency of occult lymph node metastasis in clinical N0 pulmonary adenocarcinoma with ALK rearrangement
por: Seto, Katsutoshi, et al.
Publicado: (2018)

Importance of avoiding surgery delays after initial discovery of suspected non-small-cell lung cancer in clinical stage IA patients
por: Kuroda, Hiroaki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_umjr8k9befo8se4se9klpc437r